These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 17943573

  • 1. Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis.
    Ratner P, Darken P, Wingertzahn M, Shah T.
    J Asthma; 2007 Oct; 44(8):629-33. PubMed ID: 17943573
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of inhaled ciclesonide compared with chlorofluorocarbon beclomethasone dipropionate in adults with moderate to severe persistent asthma.
    Adachi M, Ishihara K, Inoue H, Kudo K, Takahashi K, Morita Y, Masuda K, Sakai T, Kato R, Miyamoto T.
    Respirology; 2007 Jul; 12(4):573-80. PubMed ID: 17587425
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG.
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of once-daily inhaled ciclesonide in adults with mild to moderate asthma: a double-blind, placebo-controlled study.
    Adachi M, Ishihara K, Inoue H, Kudo K, Takahashi K, Morita Y, Masuda K, Takada Y, Kato R, Miyamoto T.
    Respirology; 2007 Jul; 12(4):566-72. PubMed ID: 17587424
    [Abstract] [Full Text] [Related]

  • 8. Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis.
    Brannan MD, Herron JM, Reidenberg P, Affrime MB.
    Clin Ther; 1995 Jul; 17(4):637-47. PubMed ID: 8565027
    [Abstract] [Full Text] [Related]

  • 9. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
    Wolthers OD.
    Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
    [Abstract] [Full Text] [Related]

  • 10. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
    Lipworth BJ, Kaliner MA, LaForce CF, Baker JW, Kaiser HB, Amin D, Kundu S, Williams JE, Engelstaetter R, Banerji DD.
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
    [Abstract] [Full Text] [Related]

  • 11. [Effects of H1 blocker and inhaled corticosteroids on asthmatic patients with allergic rhinitis].
    He WQ, Zheng JP, Ran PX, Liu HZ, Lin H, Cai DM, Xu JM, Zhong NS.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):157-60. PubMed ID: 12816681
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations.
    Brannan MD, Herron JM, Reidenberg P, Affrime MB.
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):39-44. PubMed ID: 9475565
    [Abstract] [Full Text] [Related]

  • 14. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR, Patel P, D'Urzo AD, Alexander M, Mehra S, Oedekoven C, Engelstätter R, Boulet LP.
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [Abstract] [Full Text] [Related]

  • 15. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.
    Patel D, Ratner P, Clements D, Wu W, Faris M, Philpot E.
    Ann Allergy Asthma Immunol; 2008 May; 100(5):490-6. PubMed ID: 18517083
    [Abstract] [Full Text] [Related]

  • 16. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma.
    von Berg A, Engelstätter R, Minic P, Sréckovic M, Garcia Garcia ML, Latoś T, Vermeulen JH, Leichtl S, Hellbardt S, Bethke TD.
    Pediatr Allergy Immunol; 2007 Aug; 18(5):391-400. PubMed ID: 17617808
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months.
    Boulet LP, Cartier A, Ernst P, Larivée P, Laviolette M.
    Can Respir J; 2004 Mar; 11(2):123-30. PubMed ID: 15045043
    [Abstract] [Full Text] [Related]

  • 19. A randomized, controlled trial to investigate the effect of ciclesonide and beclomethasone dipropionate on eye lens opacity.
    Chylack LT, Gross GN, Pedinoff A, Ciclesonide Lenticular Safety Study Group.
    J Asthma; 2008 Dec; 45(10):893-902. PubMed ID: 19085579
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.
    Boulet LP, Drollmann A, Magyar P, Timar M, Knight A, Engelstätter R, Fabbri L.
    Respir Med; 2006 May; 100(5):785-94. PubMed ID: 16427266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.